The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
Official Title: Open-label Trial of Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
Study ID: NCT00928525
Brief Summary: The purpose of this study is to determine whether Imatinib Mesylate is active in diseases - such as Desmoid Tumor and Chondrosarcoma - expressing the receptor for the platelet-derived growth factor (PDGF) both in its isoform alpha and beta
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Centro di Riferimento Oncologico - Unit of Medical Oncology, Aviano, Pordenone, Italy
I.R.C.C. - Unit of Medical Oncology, Candiolo, Torino, Italy
Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors, Bologna, , Italy
Policlinico S.Orsola Malpighi - Unit of Medical Oncology, Bologna, , Italy
Istituto Nazionale Tumori - Unit of Medical Oncology, Milano, , Italy
Istituto Nazionale Tumori Regina Elena - Unit of Medical Oncology I, Roma, , Italy
Ospedale Gradenigo - Unit of Medical Oncology, Torino, , Italy